Free Virtual Consultations. Corona Virus Related Cases Click Here.

Josie Montijo Killed, 2 Injured in Crash on Interstate 10 Near Rice Road

3 Vehicles Involved in Desert Center Accident

Fatal Accident 8

Desert Center, CA (December 15, 2019) – One person was killed and two others were injured in a multi-vehicle crash in Desert Center. The fatal accident occurred on the evening of December 15 on Interstate 10.

Three vehicles collided on westbound Interstate 10, near Rice Road. One woman was trapped inside her vehicle. Firefighters performed CPR on her, but she died. She has been identified as Josie Montijo, 33, of El Centro. Two others suffered minor injuries.

Our heartfelt condolences go out to the friends and loved ones of Josie Montijo.

#Desert Center 



November 18, 2019

Motorcycle Officer Injured in Crash at Pacific and McFadden Avenues

2 Police Vehicles Involved in Santa Ana Accident...

April 15, 2020

Motorcyclist Injured in Crash on Interstate 105 Near Wilmington Avenue

Motorcycle, Tow Truck Collide in Los Angeles Accident...

November 12, 2019

1 Injured in Crash on Interstate 580 Near Harrison Street

Car Hits Detached Trailer in Oakland Accident ...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.